Controlling inflammation in hemolytic blood disorders
Regulators of inflammation in hemolytic disease
['FUNDING_R01'] · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · NIH-11294534
This project looks at whether blocking certain immune sensors can reduce harmful inflammation in people with hemolytic blood disorders like sickle cell disease.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (nih funded) |
| Locations | 1 site (MEMPHIS, UNITED STATES) |
| Trial ID | NIH-11294534 on ClinicalTrials.gov |
What this research studies
You would hear that scientists are focusing on immune "sensor" proteins called NLRs that can trigger inflammation when red blood cells break down. The team will examine how inflammasomes and the inflammatory enzyme caspase-1 drive release of signals like IL-1β and IL-18 using laboratory models and disease-relevant samples. They plan to identify which NLRs make inflammation worse in sickle cell and other hemolytic anemias and test ways to block those pathways. The goal is to point to new drug strategies that calm inflammation and reduce complications.
Who could benefit from this research
Good fit: People living with hemolytic blood disorders, including sickle cell disease and other chronic hemolytic anemias, would be the most relevant candidates to participate or benefit from this research.
Not a fit: Patients whose hemolysis is acute, caused by transfusion reactions, or driven by unrelated immune conditions may not directly benefit from NLR-targeted approaches.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that reduce damaging inflammation and lower complications such as pain crises and organ injury in people with hemolytic diseases.
How similar studies have performed: Research on the NLRP3 inflammasome and drugs that block IL-1 has helped in some inflammatory conditions, but targeting NLRs specifically in hemolytic diseases is a newer and less-tested approach.
Where this research is happening
MEMPHIS, UNITED STATES
- ST. JUDE CHILDREN'S RESEARCH HOSPITAL — MEMPHIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KANNEGANTI, THIRUMALA-DEVI — ST. JUDE CHILDREN'S RESEARCH HOSPITAL
- Study coordinator: KANNEGANTI, THIRUMALA-DEVI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.